Efficacy and Safety of Basal-Bolus Insulin Therapy with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus Hospitalized for Hyperglycemia
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000053224
- Lead Sponsor
- Ichinomiynishi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
1) Type 1 diabetes mellitus 2) Frequent insulin injections 3) Pregnancy 4) On SGLT2 inhibitors (washout for at least 1 week is acceptable) 5) DPP4 inhibitor in once-weekly formulation 6) Once-weekly GLP-1RA 7) Undergoing chemotherapy 8) DKA or history of DKA 9) Hyperglycemic coma 10)High-dose steroids (>10 mg PSL equivalent)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method